BlackRock Inc. - FENNEC PHARMACEUTICALS INC ownership

FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 36 filers reported holding FENNEC PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 1.36 and the average weighting 0.6%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of FENNEC PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$6,346,259
-13.4%
845,041
+1.8%
0.00%
Q2 2023$7,329,952
+1606.1%
830,119
+1507.6%
0.00%
Q1 2023$429,629
-11.5%
51,638
+2.2%
0.00%
Q4 2022$485,223
+21.6%
50,544
+2.4%
0.00%
Q3 2022$399,000
+39.0%
49,367
-3.9%
0.00%
Q2 2022$287,000
-7.4%
51,369
-7.2%
0.00%
Q1 2022$310,000
+22.5%
55,339
-3.8%
0.00%
Q4 2021$253,000
-53.2%
57,499
+0.3%
0.00%
Q3 2021$541,000
+18.9%
57,321
-8.3%
0.00%
Q2 2021$455,000
-93.5%
62,487
-94.5%
0.00%
Q1 2021$7,035,000
-14.7%
1,132,769
+2.3%
0.00%
Q4 2020$8,249,000
+26.6%
1,107,204
+3.0%
0.00%
Q3 2020$6,514,000
-27.0%
1,075,033
+0.5%
0.00%
Q2 2020$8,928,000
+4386.4%
1,069,261
+3095.4%
0.00%
Q1 2020$199,000
-11.2%
33,463
-3.3%
0.00%
Q4 2019$224,000
+33.3%
34,610
-1.0%
0.00%
Q3 2019$168,000
+15.9%
34,972
-3.6%
0.00%
Q2 2019$145,000
-94.5%
36,288
-93.3%
0.00%
Q1 2019$2,618,000
-27.0%
539,779
-4.0%
0.00%
Q4 2018$3,588,000
-21.8%
562,216
+0.4%
0.00%
Q3 2018$4,590,000
-20.8%
559,787
+0.9%
0.00%
Q2 2018$5,795,000555,0440.00%
Other shareholders
FENNEC PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Sonic GP LLC 2,407,357$18,079,25117.55%
Solas Capital Management, LLC 1,725,567$12,959,0089.07%
DG Capital Management, LLC 1,143,099$8,584,6734.70%
HARBERT FUND ADVISORS, INC. 466,869$3,506,1862.56%
AIGH Capital Management LLC 373,526$2,805,1801.33%
Southpoint Capital Advisors LP 4,077,214$30,619,8770.68%
APIS CAPITAL ADVISORS, LLC 70,000$525,7000.68%
Worth Venture Partners, LLC 92,636$695,6960.41%
Lion Point Capital, LP 110,000$826,1000.37%
683 Capital Management, LLC 300,000$2,253,0000.18%
View complete list of FENNEC PHARMACEUTICALS INC shareholders